InSite Vision's P2P Acquisition

InSite Vision raised a round of funding on June 08, 2015. Investors include QLT.

InSite Vision develops novel topical anti-infective products, including AzaSite(R) (azithromycin ophthalmic solution) 1% which was launched in the United States by Inspire Pharmaceuticals for the topi…

Articles about InSite Vision's P2P Acquisition: